133 related articles for article (PubMed ID: 7492300)
1. 2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line.
Magnani M; Brandi G; Casabianca A; Fraternale A; Schiavano GF; Rossi L; Chiarantini L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):115-23. PubMed ID: 7492300
[TBL] [Abstract][Full Text] [Related]
2. 2',3'-Dideoxycytidine induced drug resistance in human cells.
Magnani M; Gazzanelli G; Brandi G; Casabianca A; Fraternale A; Chiarantini L; Rossi L
Life Sci; 1995; 57(9):881-7. PubMed ID: 7630317
[TBL] [Abstract][Full Text] [Related]
3. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine.
Chen CH; Cheng YC
J Biol Chem; 1992 Feb; 267(5):2856-9. PubMed ID: 1310674
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance of dideoxycytidine-resistant cell lines to azidothymidine.
Agarwal RP; Wang W; Yo P; Han T; Fernandez M
Biochem Pharmacol; 1999 Nov; 58(10):1603-8. PubMed ID: 10535751
[TBL] [Abstract][Full Text] [Related]
5. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
6. Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.
Rossi L; Serafini S; Schiavano GF; Casabianca A; Vallanti G; Chiarantini L; Magnani M
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):915-20. PubMed ID: 10585881
[TBL] [Abstract][Full Text] [Related]
7. Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2',3'-dideoxycytidine.
Bjerke M; Franco M; Johansson M; Balzarini J; Karlsson A
Biochem Pharmacol; 2008 Mar; 75(6):1313-21. PubMed ID: 18206854
[TBL] [Abstract][Full Text] [Related]
8. Dideoxycytidine metabolism in wild type and mutant CEM cells deficient in nucleoside transport or deoxycytidine kinase.
Ullman B
Adv Exp Med Biol; 1989; 253B():415-20. PubMed ID: 2558543
[TBL] [Abstract][Full Text] [Related]
9. In vitro toxicity and metabolism of 2',3'-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity.
Brandi G; Rossi L; Schiavano GF; Salvaggio L; Albano A; Magnani M
Chem Biol Interact; 1991; 79(1):53-64. PubMed ID: 1647888
[TBL] [Abstract][Full Text] [Related]
10. Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidine.
Brandi G; Antonelli A; Amagliani G; Albano A; Magnani M
Life Sci; 1997; 60(8):519-28. PubMed ID: 9042386
[TBL] [Abstract][Full Text] [Related]
11. Programmed cell death in 2',3'-dideoxycytidine-resistant human monoblastoid U937 cells.
Antonelli A; Luchetti F; Cerasi A; Columbaro M; Papa S; Falcieri E; Magnani M
Histochem J; 2000 Feb; 32(2):115-22. PubMed ID: 10816077
[TBL] [Abstract][Full Text] [Related]
12. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
Gao WY; Shirasaka T; Johns DG; Broder S; Mitsuya H
J Clin Invest; 1993 May; 91(5):2326-33. PubMed ID: 8387546
[TBL] [Abstract][Full Text] [Related]
13. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine.
Chen CH; Cheng YC
J Biol Chem; 1989 Jul; 264(20):11934-7. PubMed ID: 2745424
[TBL] [Abstract][Full Text] [Related]
14. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
[TBL] [Abstract][Full Text] [Related]
15. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.
Feng JY; Johnson AA; Johnson KA; Anderson KS
J Biol Chem; 2001 Jun; 276(26):23832-7. PubMed ID: 11328813
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs.
Faraj A; Agrofoglio LA; Wakefield JK; McPherson S; Morrow CD; Gosselin G; Mathe C; Imbach JL; Schinazi RF; Sommadossi JP
Antimicrob Agents Chemother; 1994 Oct; 38(10):2300-5. PubMed ID: 7530932
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
Ullman B; Coons T; Rockwell S; McCartan K
J Biol Chem; 1988 Sep; 263(25):12391-6. PubMed ID: 2842332
[TBL] [Abstract][Full Text] [Related]
18. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.
Starnes MC; Cheng YC
J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells.
Innoceta A; Galluzzi L; Ruzzo A; Andreoni F; Chiarantini L; Magnani M
Mol Cell Biochem; 2002 Feb; 231(1-2):173-7. PubMed ID: 11952160
[TBL] [Abstract][Full Text] [Related]
20. Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.
Liyanage SU; Hurren R; Voisin V; Bridon G; Wang X; Xu C; MacLean N; Siriwardena TP; Gronda M; Yehudai D; Sriskanthadevan S; Avizonis D; Shamas-Din A; Minden MD; Bader GD; Laposa R; Schimmer AD
Blood; 2017 May; 129(19):2657-2666. PubMed ID: 28283480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
